Calculating disability-adjusted-life-years lost (DALYs) in discrete-time

Cost Effectiveness and Resource Allocation

Volumn 11, Issue 1, 2013, Pages 1-6

  Larson, Bruce A ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost effectiveness; Disability adjusted life years lost; Discrete time

Indexed keywords

ACCURACY; ARTICLE; CALCULATION; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; LIFE EXPECTANCY; OUTCOME ASSESSMENT; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SKILL; STUDENT;

EID: 84882682539     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-11-18     Document Type: Article

References (16)

1. World Bank World Development Report, Investing in Health 1993 1993, New York, New York: Published for the World Bank, Oxford University Press, World Bank.
2. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994, 72(3):429-45. 2486718, 8062401.
3. Murray CJ, Acharya AK. Understanding DALYs (disability-adjusted life years). J Health Econ 1997, 16(6):703-30. 10.1016/S0167-6296(97)00004-0, 10176780.
4. Fox-Rushby J, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001, 16(3):326-331. 10.1093/heapol/16.3.326, 11527874.
5. Phanthunane P, et al. Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia. Cost Effectiveness and Resource Allocation 2011, 9(1):6. 10.1186/1478-7547-9-6, 3120770, 21569448.
6. Amarasinghe A. Cost-effectiveness implications of GP intervention to promote physical activity: evidence from Perth. Australia. Cost Effectiveness and Resource Allocation 2010, 8(1):10.
7. Rubinstein A, et al. Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires. Argentina. Cost Effectiveness and Resource Allocation 2009, 7(1):10.
8. Bachmann M. Cost effectiveness of community-based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model. Cost Effectiveness and Resource Allocation 2009, 7(1):2. 10.1186/1478-7547-7-2, 2630929, 19146668.
9. Hansen K, Chapman G. Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease. Cost Effectiveness and Resource Allocation 2008, 6(1):14. 10.1186/1478-7547-6-14, 2517588, 18662389.
10. Dalziel K, Segal L, Mortimer D. Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?. Cost Effectiveness and Resource Allocation 2008, 6(1):9. 10.1186/1478-7547-6-9, 2413209, 18489788.
11. Robberstad B, Hemed Y, Norheim O. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation 2007, 5(1):3. 10.1186/1478-7547-5-3, 1808049, 17316431.
12. Bishai D, Hyder A. Modeling the cost effectiveness of injury interventions in lower and middle income countries: opportunities and challenges. Cost Effectiveness and Resource Allocation 2006, 4(1):2. 10.1186/1478-7547-4-2, 1379660, 16423285.
13. Shim E, et al. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania. Vaccine 2009, 27(51):7167-7172. 10.1016/j.vaccine.2009.09.027, 3272373, 19925948.
14. Elbasha EH. Discrete time representation of the formula for calculating DALYs. Health Econ 2000, 9(4):353-365. 10.1002/1099-1050(200006)9:4<353::AID-HEC519>3.0.CO;2-V, 10862078.
15. Drummond MF. Methods for the Economic Evaluation of Health Care Programmes 2005, Oxford: Oxford University Press, 3.
16. Mathers CD, et al. Chapter 5: Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates. Global Burden of Disease and Risk Factors 2006, Washington, D.C: The World Bank, Lopez AD.